Synopsis
Although there was a mild recovery in the March quarter of the past fiscal year, it was only in the June quarter that the company reported better than expected numbers. The performance was driven by recovery across hospitals and diagnostics, continued focus on cost optimization and incremental upside from Covid-19 tests.
ET Intelligence Group: The stock of Fortis Healthcare has generated a meagre 7% annual return over the past five years compared with 28% earned by its larger peer Apollo Hospitals. However, scenario may improve given the efforts of the new management of Fortis to turn around the business and overall uptick in the healthcare sector as the proportion of high margin, non-Covid revenue improves.
After a sluggish performance in FY18 and FY19 under
- FONT SIZE
AbcSmall
AbcMedium
AbcLarge
Sign in to read the full article
You’ve got this Prime Story as a Free Gift
₹399/month
Monthly
PLAN
Billed Amount ₹399
₹208/month
(Save 49%)
Yearly
PLAN
Billed Amount ₹2,499
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
₹150/month
(Save 63%)
2-Year
PLAN
Billed Amount ₹3,599
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
Already a Member? Sign In now
Get Offer
Why ?
![]()
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
![]()
Clean experience with
Minimal Ads-
Comment & Engage with ET Prime community ![]()
Exclusive invites to Virtual Events with Industry Leaders -
A trusted team of Journalists & Analysts who can best filter signal from noise
For all the latest Business News Click Here
For the latest news and updates, follow us on Google News.
